Error - Could not copy link. Try again
Page link copied
Weekly Round-up

Medicinal Cannabis Matters | Friday roundup 24th January 2025.

Medicinal Cannabis Matters | Friday roundup 24th January 2025

Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week. 

This week, we delve into a new study investigating the use of medicinal cannabis for late-stage dementia, explore how cannabinoids present a safe and effective alternative for pain relief, and look into how medicinal cannabis could play a key role in addressing the opioid crisis.

Medicinal cannabis to be used as late-stage dementia treatment in ‘first of its kind’ study.
Researchers in Kentucky are preparing to launch a groundbreaking study to examine the potential benefits of cannabis-based medicines for individuals living with late-stage dementia. Spanning 12 weeks, the study aims to explore how these treatments can enhance the quality of life during the end-of-life stages for dementia patients.

Read More

Cannabinoids offer new hope for safe and effective pain relief.

Chronic pain remains a significant global health challenge, with many existing treatments hindered by unwanted side effects. In a recent study, Yale researchers have uncovered alternative compounds that show promising therapeutic potential.

Read More

Could medicinal cannabis be a solution to the opioid crisis?  

Recent research by Ruth Fisher, PhD, highlights the potential of medicinal cannabis in aiding individuals to reduce their reliance on opioids. Additionally, numerous studies have reported a decrease in opioid-related deaths and prescriptions among patients who have initiated medicinal cannabis treatment.

Read more

If you’re interested in learning more about medicinal cannabis and how it can help you manage your condition, fill out the simple form linked below. Start your journey today with the only award-winning clinic in Jersey, Guernsey and the Isle of Man. Check your eligibility today. 

https://www.medicann.co.uk/book-consultation/eligibility/

Disclaimer: 

This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann. 

Other articles